Patient with SLN+ (NÂ =Â 24) | Tumor associated expression | ||
---|---|---|---|
Semi-quantitative scoring | Percentage estimates—tumor | ||
PD-L1 score—tumor | PD-L1—peritumoral | ||
1 | 1Â T, very weak | 1 | 3 |
2 | 4, predominantly T, peripheral | 1 | 40 |
3 | Melanin confounds | 2 | NA |
4 | 0 | 2 (adjacent subcapsular sinus) | 0 |
5 | 4 T/NT | 2 | 30 |
6 | 2, predominantly NT | 3 | 3 |
7 | 0 | 3 (adjacent subcapsular sinus) | 0 |
8 | 2.5, predominantly NT | 3 | 10 |
9 | 4.5, predominantly T, weak | 2 (adjacent sinus) | 50 |
10 | Melanin confounds | 0 | NA |
11 | 1 T | 2.5 | <1 |
12 | 0a | 2 | 0 |
13 | 1 T | 1 | <1 |
14 | 2.5 NT | 2 | 10 |
15 | 2 predominantly NT | 3 | 3 |
16 | 1 T | 2 | 1 |
17 | Melanin confounds | 0 | NA |
18 | 1 | 1 | <1 |
19 | 1 NT | 2.5 | <1 |
20 | 2T?, melanin confounds | 2 | <1 |
21 | 4, predominantly T, peripheral | 3.5 | 40 |
22 | 5, predominantly T | 2 | 90 |
23 | 4 | 0 | 40 |
24 | 4.5 T/NT | 0 | 70 |